Suppr超能文献

N-甲基-D-天冬氨酸受体和非N-甲基-D-天冬氨酸受体在向未麻醉大鼠下丘脑室旁核微量注射L-谷氨酸的心血管效应中的作用

Role of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the cardiovascular effects of L-glutamate microinjection into the hypothalamic paraventricular nucleus of unanesthetized rats.

作者信息

Busnardo Cristiane, Tavares Rodrigo F, Corrêa Fernando M A

机构信息

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

出版信息

J Neurosci Res. 2009 Jul;87(9):2066-77. doi: 10.1002/jnr.22028.

Abstract

We report on the cardiovascular effects of L-glutamate (L-glu) microinjection into the hypothalamic paraventricular nucleus (PVN) as well as the mechanisms involved in their mediation. L-glu microinjection into the PVN caused dose-related pressor and tachycardiac responses in unanesthetized rats. These responses were blocked by intravenous (i.v.) pretreatment with the ganglion blocker pentolinium (PE; 5 mg/kg), suggesting sympathetic mediation. Responses to L-glu were not affected by local microinjection of the selective non-NMDA receptor antagonist NBQX (2 nmol) or by local microinjection of the selective NMDA receptor antagonist LY235959 (LY; 2 nmol). However, the tachycardiac response was changed to a bradycardiac response after treatment with LY235959, suggesting that NMDA receptors are involved in the L-glu heart rate response. Local pretreatment with LY235959 associated with systemic PE or dTyr(CH(2))(5)(Me)AVP (50 microg/kg) respectively potentiated or blocked the response to L-glu, suggesting that L-glu responses observed after LY235959 are vasopressin mediated. The increased pressor and bradycardiac responses observed after LY + PE was blocked by subsequent i.v. treatment with the V(1)-vasopressin receptor antagonist dTyr(CH(2))(5)(Me)AVP, suggesting vasopressin mediation. The pressor and bradycardiac response to L-glu microinjection into the PVN observed in animals pretreated with LY + PE was progressively inhibited and even blocked by additional pretreatment with increasing doses of NBQX (2, 10, and 20 nmol) microinjected into the PVN, suggesting its mediation by local non-NMDA receptors. In conclusion, results suggest the existence of two glutamatergic pressor pathways in the PVN: one sympathetic pathway that is mediated by NMDA receptors and a vasopressinergic pathway that is mediated by non-NMDA receptors.

摘要

我们报告了向下丘脑室旁核(PVN)微量注射L-谷氨酸(L-glu)的心血管效应及其介导机制。向未麻醉大鼠的PVN微量注射L-glu会引起剂量相关的升压和心动过速反应。静脉注射(i.v.)神经节阻滞剂喷托铵(PE;5mg/kg)预处理可阻断这些反应,提示其通过交感神经介导。对L-glu的反应不受局部微量注射选择性非NMDA受体拮抗剂NBQX(2nmol)或局部微量注射选择性NMDA受体拮抗剂LY235959(LY;2nmol)的影响。然而,用LY235959处理后,心动过速反应转变为心动过缓反应,提示NMDA受体参与L-glu的心率反应。分别与全身PE或dTyr(CH₂)₅(Me)AVP(50μg/kg)联合进行LY235959局部预处理,可增强或阻断对L-glu的反应,提示LY235959处理后观察到的L-glu反应由血管加压素介导。LY + PE后观察到的升压和心动过缓反应增加,被随后静脉注射V₁-血管加压素受体拮抗剂dTyr(CH₂)₅(Me)AVP阻断,提示血管加压素介导。在LY + PE预处理的动物中,向PVN微量注射L-glu所观察到的升压和心动过缓反应,被向PVN微量注射递增剂量的NBQX(2、10和20nmol)进行额外预处理逐渐抑制甚至阻断,提示其由局部非NMDA受体介导。总之,结果提示PVN中存在两条谷氨酸能升压途径:一条由NMDA受体介导的交感神经途径和一条由非NMDA受体介导的血管加压素能途径。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验